GeneDx to Participate in Upcoming Investor Conferences
GeneDx to Participate in Upcoming Investor Conferences
STAMFORD, Conn., May 22, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in two upcoming investor conferences in June:
康涅狄格州斯坦福，2024年5月22日（GLOBE NEWSWIRE）——通過基因組洞察改善健康狀況的領導者GenedX（納斯達克股票代碼：WGS）今天宣佈，公司管理層將參加即將於6月舉行的兩次投資者會議：
- Jefferies Healthcare Conference - New York City, New York
Fireside chat on Wednesday, June 5 at 9:00 a.m. ET - 44th Annual Goldman Sachs Global Healthcare Conference - Miami, Florida
Fireside chat on Monday, June 10 at 3:20 p.m. ET
- 傑富瑞醫療會議-紐約市，紐約
美國東部時間6月5日星期三上午9點的爐邊談話 - 第 44 屆高盛全球醫療保健年會-佛羅里達州邁阿密
美國東部時間6月10日星期一下午3點20分的爐邊談話
Live and archived webcasts of the presentation will be available on the "Events" section of the GeneDx investor relations website at ir.genedx.com/news-events/events.
該演講的直播和存檔網絡直播將在GenedX投資者關係網站的 “活動” 部分提供，網址爲 ir.genedx.com/新聞活動/活動。
About GeneDx
關於 GenedX
At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world's largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It all starts with a single test. For more information, please visit genedx.com and connect with us on LinkedIn, X, Facebook, and Instagram.
Investor Relations Contact:
investors@GeneDx.com
投資者關係聯繫人：
investors@GeneDx.com
Media Contact:
press@GeneDx.com
媒體聯繫人：
press@GeneDx.com
譯文內容由第三人軟體翻譯。